Protagonist Therapeutics Inc (PTGX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PTGX.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PTGX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PTGX as an investment opportunity.
- The percent of analysts bearish on the stock of PTGX is less than nearly 100% of all US stocks.
- PTGX has a higher percentage of analysts bullish on the stock than 84.03% of all US stocks.
- PTGX has a higher average analyst price target than 77.29% of stocks in the small market cap category.
- Protagonist Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 75.71% of all US stocks.
- Protagonist Therapeutics Inc's variance in analysts' estimates is less than 67.44% of Pharmaceutical Products stocks.
- The number of analysts covering the stock of PTGX is greater than 33.53% of Pharmaceutical Products stocks.
- Protagonist Therapeutics Inc's change in bullishness amongst analysts is less than nearly 100% of all US stocks.
What is the outlook for PTGX? Use POWR Ratings for clearer insight into price direction.